| Year |
Citation |
Score |
| 2022 |
Mahdi WA, Absar MS, Choi S, Yang VC, Kwon YM. Enhanced control of bioactivity of tissue plasminogen activator (tPA) through domain-directed enzymatic oxidation of terminal galactose. Bioimpacts : Bi. 12: 479-486. PMID 36644546 DOI: 10.34172/bi.2022.23477 |
0.639 |
|
| 2014 |
Absar S, Kwon YM, Ahsan F. Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis. Journal of Controlled Release. 177: 42-50. PMID 24417965 DOI: 10.1016/J.Jconrel.2013.12.036 |
0.443 |
|
| 2014 |
He H, Ye J, Wang Y, Liu Q, Chung HS, Kwon YM, Shin MC, Lee K, Yang VC. Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. Journal of Controlled Release : Official Journal of the Controlled Release Society. 176: 123-32. PMID 24374002 DOI: 10.1016/J.Jconrel.2013.12.019 |
0.369 |
|
| 2014 |
Absar S, Nahar K, Choi S, Ahsan F, Yang VC, Kwon YM. Serum albumin-protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromolecules. Journal of Biomedical Materials Research. Part A. 102: 2481-90. PMID 23946132 DOI: 10.1002/Jbm.A.34916 |
0.657 |
|
| 2013 |
Shin MC, Zhang J, David AE, Trommer WE, Kwon YM, Min KA, Kim JH, Yang VC. Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 169-78. PMID 23973813 DOI: 10.1016/J.Jconrel.2013.08.016 |
0.357 |
|
| 2013 |
He H, Sheng J, David AE, Kwon YM, Zhang J, Huang Y, Wang J, Yang VC. The use of low molecular weight protamine chemical chimera to enhance monomeric insulin intestinal absorption. Biomaterials. 34: 7733-43. PMID 23863452 DOI: 10.1016/J.Biomaterials.2013.06.047 |
0.305 |
|
| 2013 |
Absar S, Nahar K, Kwon YM, Ahsan F. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy. Pharmaceutical Research. 30: 1663-76. PMID 23468049 DOI: 10.1007/S11095-013-1011-X |
0.339 |
|
| 2013 |
Absar S, Choi S, Ahsan F, Cobos E, Yang VC, Kwon YM. Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis. Thrombosis Research. 131: e91-9. PMID 23269380 DOI: 10.1016/J.Thromres.2012.11.030 |
0.645 |
|
| 2012 |
Absar S, Choi S, Yang VC, Kwon YM. Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 157: 46-54. PMID 21930168 DOI: 10.1016/J.Jconrel.2011.09.060 |
0.647 |
|
| 2011 |
Lee JY, Choi YS, Suh JS, Kwon YM, Yang VC, Lee SJ, Chung CP, Park YJ. Cell-penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy. International Journal of Cancer. 128: 2470-80. PMID 20669230 DOI: 10.1002/Ijc.25578 |
0.35 |
|
| 2010 |
Huang Y, Park YS, Wang J, Moon C, Kwon YM, Chung HS, Park YJ, Yang VC. ATTEMPTS system: a macromolecular prodrug strategy for cancer drug delivery. Current Pharmaceutical Design. 16: 2369-76. PMID 20618157 DOI: 10.2174/138161210791920441 |
0.434 |
|
| 2010 |
Choi YS, Lee JY, Suh JS, Kwon YM, Lee SJ, Chung JK, Lee DS, Yang VC, Chung CP, Park YJ. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials. 31: 1429-43. PMID 19954842 DOI: 10.1016/J.Biomaterials.2009.11.001 |
0.35 |
|
| 2009 |
Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD, David AE, Yang VC. L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). Journal of Controlled Release : Official Journal of the Controlled Release Society. 139: 182-9. PMID 19577600 DOI: 10.1016/J.Jconrel.2009.06.027 |
0.331 |
|
| 2009 |
Li YT, Kwon YM, Spangrude GJ, Liang JF, Chung HS, Park YJ, Yang VC. Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy. Journal of Biomedical Materials Research. Part A. 91: 209-20. PMID 18814276 DOI: 10.1002/Jbm.A.32204 |
0.356 |
|
| 2008 |
Kwon YM, Li Y, Naik S, Liang JF, Huang Y, Park YJ, Yang VC. The ATTEMPTS delivery systems for macromolecular drugs. Expert Opinion On Drug Delivery. 5: 1255-66. PMID 18976135 DOI: 10.1517/17425240802498059 |
0.444 |
|
| 2008 |
Kwon YM, Li YT, Liang JF, Park YJ, Chang LC, Yang VC. PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 130: 252-8. PMID 18652856 DOI: 10.1016/J.Jconrel.2008.06.017 |
0.389 |
|
| 2008 |
Moon C, Kwon YM, Lee WK, Park YJ, Chang LC, Yang VC. A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation. Journal of Biomedical Materials Research. Part A. 84: 238-46. PMID 17607767 DOI: 10.1002/Jbm.A.31452 |
0.409 |
|
| 2007 |
Moon C, Kwon YM, Lee WK, Park YJ, Yang VC. In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 124: 43-50. PMID 17904680 DOI: 10.1016/J.Jconrel.2007.08.029 |
0.412 |
|
| 2004 |
Kwon YM, Kim SW. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition Pharmaceutical Research. 21: 339-343. PMID 15032317 DOI: 10.1023/B:Pham.0000016248.30579.2F |
0.395 |
|
| 2003 |
Kwon YM, Kim SW. New biodegradable polymers for delivery of bioactive agents Macromolecular Symposia. 201: 179-186. DOI: 10.1002/Masy.200351121 |
0.449 |
|
| 2002 |
Zhong Z, Dijkstra PJ, Feijen J, Kwon YM, Bae YH, Kim SW. Synthesis and aqueous phase behavior of thermoresponsive biodegradable poly(D,L‐3‐methylglycolide)‐block‐poly(ethylene glycol)‐block‐poly(D,L‐3‐methylglycolide) triblock copolymers Macromolecular Chemistry and Physics. 203: 1797-1803. DOI: 10.1002/1521-3935(200208)203:12<1797::Aid-Macp1797>3.0.Co;2-A |
0.387 |
|
| 2001 |
Kwon YM, Baudys M, Knutson K, Kim SW. In situ study of insulin aggregation induced by water-organic solvent interface Pharmaceutical Research. 18: 1754-1759. PMID 11785697 DOI: 10.1023/A:1013334916162 |
0.359 |
|
| Show low-probability matches. |